Navigation Links
Amgen Announces Voting Results Of Annual Meeting of Stockholders
Date:5/20/2011

SEATTLE, May 20, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN), today announced results of voting at the Company's Annual Meeting of Stockholders, held at The Fairmont Olympic Hotel in Seattle, Wash. Approximately 86.32 percent of outstanding shares were represented at the meeting.

The director nominees David Baltimore, Frank J. Biondi, Jr., Francois de Carbonnel, Vance D. Coffman, Rebecca M. Henderson, Frank C. Herringer, Gilbert S. Omenn, Judith C. Pelham, J. Paul Reason, USN (Retired), Leonard D. Schaeffer, Kevin W. Sharer and Ronald D. Sugar were each reelected to Amgen's Board of Directors, each receiving a majority of 'For' votes of the votes cast. With the reelection of these directors, Amgen currently has 12 directors.

With approximately 98.54 percent of 'For' votes of the votes cast, stockholders ratified Ernst & Young as Amgen's independent registered public accountants for the year ending Dec. 31, 2011.

Stockholders approved an advisory vote, commonly known as "Say-on-Pay." The non-binding proposal gives shareholders the opportunity to endorse or not endorse executive pay programs and policies. Say-on-Pay received approximately 55.58 percent of the votes cast 'For' the proposal. In connection with this advisory vote, stockholders voted that executive compensation should be voted on annually at 89.37 percent of the votes cast.

Stockholders approved a nonbinding resolution recommending that the Company take steps to permit shareholders to act by the written consent of the majority of shares outstanding. The proposal received approximately 50.19 percent of votes cast 'For' the proposal and approximately 38.10 percent of the votes outstanding 'For' the proposal.

About Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first comp
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
2. Amgen Oncology Data to be Presented at ASCO Annual Meeting
3. Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference
4. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
5. Amgen to Present at the Deutsche Bank 36th Annual Healthcare Conference
6. Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
7. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
8. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
9. Amgen to Webcast 2011 Business Review Meeting on April 21
10. Amgen Announces Webcast of 2011 First Quarter Financial Results
11. Amgen Establishes Commercial Operations in Brazil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015  AT&T 1 and Royal Philips ...  is the connectivity provider for Philips GoSafe, Philips, leading ... provide peace of mind to seniors at home or ... active lives with the confidence that they can get ... network 2 helps power GoSafe and connects seniors ...
(Date:3/3/2015)... 2015   VWR  (NASDAQ:  VWR), a leading, ... announced today the expansion of its distribution agreement ... allows VWR increased access to NEB,s growing product ... and Puerto Rico.  In addition, customers will now ... platform, sales organization, and VWRCATALYST, our onsite services ...
(Date:3/3/2015)... , March 3, 2015  The eleventh annual Tucson ... of the world,s top research scientists, academics, oncologists and ... theories and learn about new outcomes in patient treatments ... Each year Ventana Medical Systems, Inc. ... sponsors the Tucson Symposium at the Hilton El Conquistador ...
Breaking Medicine Technology:AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4VWR Announces Expansion of Distribution Agreement with New England Biolabs 2Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2
... Data presented at the 2008 iSBTc Annual Meeting -, ... 11:00 a.m. ET to discuss,results -, BRANFORD, Conn., ... today preliminary data from an ongoing Phase II,trial of ... of patients with unresectable Stage III or Stage IV ...
... at AASLD annual meeting, Pivotal Phase III ... failed prior treatment, SAN FRANCISCO, Nov. 1 ... that a planned interim analysis of a,Phase II ... C,protease inhibitor, in combination with peginterferon and ribavirin,markedly ...
Cached Medicine Technology:CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 2Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 3Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 4Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 5Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 6Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 8Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 9Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 10
(Date:3/3/2015)... 2015 The human augmentation market is ... market. The wearable augmentation sector is predicted to outpace ... the upcoming years. , The eye-wear sector dominates ... big number of new products launches in the region. ... technological advancements as well as the rising demand for ...
(Date:3/3/2015)... 2015 Daylight Savings Time may lead to ... has tips for parents. , Parents and their children may ... a.m. when they set their clocks forward one hour for ... day -- one hour earlier -- you will have already ... start thinking about “sleep hygiene” for their kids and teens ...
(Date:3/3/2015)... Sunday, March 1, through Saturday, March 7, is National ... every region of the country is at risk for some ... is sharing the following tips from the Centers for ... safe in the event of severe weather: , Winter storms, ... to prevent loss of body heat. Wear warm, loose-fitting, lightweight ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 -- vRad ( Virtual Radiologic ... today announced that Arlene Sussman, MD, a highly regarded ... live webinar to explore how telemedicine best practices allow ... services for women virtually anywhere. Click here ... Line” on March 4, 2015 at 1:00 pm CT. ...
(Date:3/3/2015)... CA (PRWEB) March 03, 2015 ... and collaboration, announces Mirroring360 is now available for Epson® ... download from the Moverio Apps Market , iPod, ... mobile device experience to the Epson Moverio smart glasses ... usage models. , The Epson smart glasses ...
Breaking Medicine News(10 mins):Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Amica Insurance Has Tips for National Severe Weather Preparedness Week 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3
... NEW YORK (Oct. 17, 2007) -- Two reports from ... light on male infertility. A first report shows that ... varicose veins in the scrotum -- also results in ... researchers demonstrate that once a common, simple surgery is ...
... Sessions relieve pain and help improve daily function, researchers ... stretching and aerobic workouts in warm water may help ... knee or hip osteoarthritis. , That finding was offered ... 800 patients. , In the studies, participants did aquatic ...
... into treatment, cure for,devastating lung disease, WASHINGTON, ... announced the passage of important legislation,that recognizes the ... fibrosis (IPF), a deadly lung disease with no ... diseases which claims 40,000 lives a,year, the same ...
... Highlights to Include New Research on HIV Screening, ... Bullying, WASHINGTON, Oct. 17 More than ... Nov. 3-7 to address the,nation,s top public health ... Annual Meeting., The conference will feature leading ...
... More Space in the Future to Keep Up ... Technologies,Inc. (Pink Sheets: RBRM), an emerging medical device ... Phillips, Ph.D., today,announced it is increasing its manufacturing ... medical devices and products. The company recently,contracted construction ...
... Suit Against Medtronic Inc., Medtronic Puerto Rico, Inc., and Medtronic Puerto Rico Operations ... Lead Used with a Medtronic Implantable ... Defibrillator, Class Action ... Implanted with Leads Manufactured by Medtronic, Inc., NEW YORK, Oct. 17 ...
Cached Medicine News:Health News:The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell 2Health News:Water Workouts Work for Arthritis Patients 2Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 2Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 3Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 4Health News:Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting, Nov. 3-7 2Health News:ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand 2Health News:ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand 3Health News:Parker Waichman Alonso LLP, Along with Smith & Nevares, Salas & Co. and Becnel 2Health News:Parker Waichman Alonso LLP, Along with Smith & Nevares, Salas & Co. and Becnel 3
Modified Freer periosteal elevator, #163, strong curve, 21 cm....
Williger periosteal elevator, 6 1/4", sharp, 5 mm wide....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Seldin periosteal elevator #23, flat handle, 19.5 cm, 7-3/4"....
Medicine Products: